Latest ORTX reports update at 2023-11-13: 2023-Q32022-Q42022-Q3
Orchard Therapeutics plc logo

Orchard Therapeutics plc ORTX

$ 4.93 1.02%

Country

britainBritain

IPO year

2018

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

CEO

Prof. Bobby Gaspar Ph.D., M.D.

Employees in the company

252

Shares

128 M

Market Cap[1]

$ 90.8 M

EBITDA (LTM)

$ -94.9 M

P/E (LTM)

-6.94

P/S (LTM)

4.4

EPS (LTM)

-0.71

Other stocks of industry "Biotechnology"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.